Hugo Sigman

Centro de Ingeniería Genética y Biotecnología — CU

Biochemistry, Genetics and Molecular Biology · Life Sciences

4h-index236citations5works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Protein Kinase Regulation and GTPase Signaling(2), PI3K/AKT/mTOR signaling in cancer(2), Peptidase Inhibition and Analysis(2), HER2/EGFR in Cancer Research(1), Monoclonal and Polyclonal Antibodies Research(1)

Publications5 total

Pharmacological and safety evaluation of CIGB-300, a casein kinase 2 inhibitor peptide, administered intralesionally to patients with cervical cancer stage IB2/II
Journal of Cancer Research & Therapy·2013· 14 citedOpen Access
CIGB-300, a synthetic peptide-based drug that targets the CK2 phosphoaceptor domain. Translational and clinical research
Molecular and Cellular Biochemistry·2011· 43 cited
Safety and preliminary efficacy data of a novel Casein Kinase 2 (CK2) peptide inhibitor administered intralesionally at four dose levels in patients with cervical malignancies
BMC Cancer·2009· 80 citedOpen Access
CIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in vitro and in vivo
Molecular and Cellular Biochemistry·2008· 99 cited
El conflicto agropecuario en Argentina: reflexiones de un productor
Le Monde diplomatique en español·2008

Frequent Co-authors

Daniel F. Alonso(4), Silvio E. Perea(3), Idania Baladrón(3), Yasser Perera(3), Carmen Valenzuela(3), Pedro López‐Saura(3), Agueda Santana(3), Alina Díaz(3), Roberto Gómez(3), Luís Herrera(3), Boris Acevedo(3), Osvaldo Reyes(2), Hernán G. Fariña(2), Jeovanis Gil(2), Arielis Rodríguez(2), M. Meira e Cruz(2), Lila Castellanos(2), Aniel Sánchez(2), Lázaro Betancourt(2), Vladimir Besada(2)